Literature DB >> 1415616

Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart.

G K Asimakis1, K Inners-McBride, G Medellin, V R Conti.   

Abstract

The hypothesis that brief ischemia (preconditioning) protects the isolated heart from prolonged global ischemia was tested. Isovolumic rat hearts were preconditioned with either 5 min of ischemia followed by 5 min of perfusion (P1) or two 5-min episodes of ischemia separated by 5 min of perfusion (P2). Control hearts received no preconditioning. All hearts received 40 min of sustained ischemia and 30 min of reperfusion. Preconditioning (P1 or P2) significantly (P less than 0.0005) improved recovery of the rate-pressure product; percentage recoveries were 17.8 +/- 3.2 (n = 14), 59.9 +/- 5.5 (n = 6), and 46.4 +/- 4.7 (n = 8) for control, P1, and P2, respectively. Improved functional recovery of preconditioned hearts was associated with reduced end-diastolic pressure and improved myocardial perfusion. During the 40-min ischemic period, myocardial pH decreased from approximately 7.4 to 6.3 +/- 0.1 (n = 7) in the control hearts and to 6.7 +/- 0.1 (n = 7) in the preconditioned hearts (P less than 0.01). Also during the 40-min ischemic period, myocardial lactate (expressed as nmol/mg protein) increased to 146 +/- 11 (n = 7) and 101 +/- 12 (n = 8) in control and preconditioned hearts, respectively (P less than 0.02). The results demonstrate that a brief episode of ischemia can protect the isolated rat heart from a prolonged period of ischemia. This protection is associated with decreased tissue acidosis and anaerobic glycolysis during the sustained ischemic period.

Entities:  

Mesh:

Year:  1992        PMID: 1415616     DOI: 10.1152/ajpheart.1992.263.3.H887

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  38 in total

Review 1.  If ischemic preconditioning is the gold standard, has a platinum standard of cardioprotection arrived? Comparison with NHE inhibition.

Authors:  R J Gumina; G J Gross
Journal:  J Thromb Thrombolysis       Date:  1999-07       Impact factor: 2.300

Review 2.  Regulation of cardiac sarcolemmal Na+/H+ exchanger activity: potential pathophysiological significance of endogenous mediators and oxidant stress.

Authors:  M Avkiran; A K Snabaitis
Journal:  J Thromb Thrombolysis       Date:  1999-07       Impact factor: 2.300

3.  Electron paramagnetic resonance monitoring of ischemia-induced myocardial oxygen depletion and acidosis in isolated rat hearts using soluble paramagnetic probes.

Authors:  Denis A Komarov; Ilirian Dhimitruka; Igor A Kirilyuk; Dmitrii G Trofimiov; Igor A Grigor'ev; Jay L Zweier; Valery V Khramtsov
Journal:  Magn Reson Med       Date:  2011-12-12       Impact factor: 4.668

4.  Hypoxic preconditioning in isolated rat hearts: non-involvement of activation of adenosine A1 receptor, Gi protein, and ATP-sensitive K+ channel.

Authors:  K Yabe; Y Nasa; S Takeo
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

5.  Biphasic changes in relaxation following reperfusion after myocardial ischemia.

Authors:  S M Mosca; M Carriquiriborde; H E Cingolani
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

6.  Preconditioning rabbit cardiomyocytes: role of pH, vacuolar proton ATPase, and apoptosis.

Authors:  R A Gottlieb; D L Gruol; J Y Zhu; R L Engler
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

7.  Preconditioning the human heart.

Authors:  A M Alkhulaifi
Journal:  Ann R Coll Surg Engl       Date:  1997-01       Impact factor: 1.891

Review 8.  Ischemic preconditioning: a brief review.

Authors:  K A Reimer; R B Jennings
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

Review 9.  Preconditioning--a reappraisal of protection.

Authors:  L M King; L H Opie
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

10.  Preconditioning reduces QTc value in patients with first non-ST-segment elevation myocardial infarction (NSTEMI).

Authors:  Christodoulos E Papadopoulos; Haralampos I Karvounis; Georgios E Parharidis; Georgios E Louridas
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-10       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.